Characterizing Dual Combination Therapy Use In Treatment Escalation Of Hypertension: Real-world Evidence From Multinational Cohorts

被引：0
|
作者：
Lu, Yuan
Li, Jing
Wang, Xialin
Dorajoo, Sreemanee
Feng, Mengling
Hsu, Min-Huei
Hsu, Jason C. C.
Hwang, Jiyoung
Iqbal, Usman
Chen, Zhengfeng J.
Jonnagaddala, Jitendra
机构：
来源：
CIRCULATION | 2021年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14094
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
    You, Seng Chan
    Jung, Sungjae
    Swerdet, Joel N.
    Ryan, Patrick B.
    Schuemie, Martijn J.
    Suchard, Marc A.
    Lee, Seongwon
    Cho, Jaehyeong
    Hripcsak, George
    Park, Rae Woong
    Park, Sungha
    [J]. KOREAN CIRCULATION JOURNAL, 2020, 50 (01) : 52 - 68
  • [2] Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe
    Desideri, Giovambattista
    Cipelli, Riccardo
    Pegoraro, Valeria
    Ripellino, Claudio
    Miroddi, Marco
    Meto, Suada
    Gori, Mario
    Fabrizzi, Paolo
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (05) : 733 - 743
  • [3] Extemporaneous combination therapy with nebivolol/valsartan for the treatment of hypertension: a study of real-world evidence in Europe
    Desideri, Giovambattista
    Pegoraro, Valeria
    Cipelli, Riccardo
    Ripellino, Claudio
    Miroddi, Marco
    Meto, Suada
    Gori, Mario
    Fabrizzi, Paolo
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (07) : 1211 - 1219
  • [4] Extemporaneous combination therapy with nebivolol/ramipril for the treatment of hypertension: a real-world evidence study in Europe
    Desideri, Giovambattista
    Pegoraro, Valeria
    Cipelli, Riccardo
    Ripellino, Claudio
    Miroddi, Marco
    Meto, Suada
    Gori, Mario
    Fabrizzi, Paolo
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (07) : 1093 - 1102
  • [5] BASELINE CHARACTERISTICS AND ON-TREATMENT PREDICTORS OF RESPONSES FROM REAL-WORLD PATIENT COHORTS: INTERIM RESULTS OF THE MULTINATIONAL PROPHESYS COHORTS
    Ferenci, P.
    Shiffman, M. L.
    Puoti, M.
    Orlandini, A.
    Caruntu, F. A.
    Ouzan, D.
    Bozic, M.
    Bourliere, M.
    Silva, G. F.
    Schuller, J.
    Mulkay, J. -P.
    Horban, A.
    Messinger, D.
    Tietz, A.
    Mangia, A.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S108 - S108
  • [6] Real-world Use of Upfront Combination Therapy in Pulmonary Arterial Hypertension (PAH) Patients
    Paoli, C.
    Tang, W.
    Panjabi, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [7] Real-world Treatment Patterns and Clinical Outcomes Associated With Palbociclib Combination Therapy: A Multinational, Pooled Analysis From the Ibrance Real World Insights Study
    Mycock, Katie
    Hanson, Kent A.
    Taylor-Stokes, Gavin
    Milligan, Gary
    Atkinson, Christian
    Mitra, Debanjali
    Preciado, Salena
    Law, Ernest H.
    [J]. CLINICAL THERAPEUTICS, 2022, 44 (12) : 1588 - 1601
  • [8] EXPERIENCE WITH MACITENTAN TRIPLE COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION: REAL-WORLD EVIDENCE FROM THE OPUS REGISTRY
    McConnell, John
    Chin, Kelly
    Kim, Nick
    McLaughlin, Vallerie
    Flynn, Megan
    Ong, Rose
    Wetherill, Graham
    Channick, Richard
    [J]. CHEST, 2020, 158 (04) : 2217A - 2219A
  • [9] Macitentan and Tadalafil Combination Therapy in Incident and Prevalent Pulmonary Arterial Hypertension: Real-World Evidence from the OPUS/OrPHeUS Studies
    Chin, Kelly M.
    Channick, Richard
    Kim, Nick H.
    Macdonald, Gwen
    Ong, Rose
    Martin, Nicolas
    Senatore, Assunta
    McLaughlin, Vallerie V.
    [J]. ADVANCES IN THERAPY, 2024,
  • [10] Combination therapy use in patients with psoriatic arthritis in a real-world dataset
    Wu, A. M.
    Zhang, A. J.
    Scher, J.
    Gottlieb, A.
    Perez-Chada, L.
    Merola, J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S29 - S29
12345